Xywav 0.5 g/mL oral solution Images
Generic Name: calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate
This medication has been identified as Xywav 0.5 g/mL oral solution. It is supplied by Jazz Pharmaceuticals plc.
Xywav is used in the treatment of Idiopathic Hypersomnia; Narcolepsy and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Xywav 0.5 g/mL oral solution is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Xywav
- Generic Name
- calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate
- Strength
- 0.5 g/mL oral solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Jazz Pharmaceuticals plc
- National Drug Code (NDC)
- 68727-0150
More about Xywav (calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
